Acquirer
Astellas Pharma
Astellas Pharma appears as the named buyer in 7 recorded transactions between 2016 and 2020, most often in healthcare & life sciences.
Record
What Astellas Pharma has bought
Every recorded transaction where Astellas Pharma is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| iota Biosciences | Healthcare & Life Sciences | — | 2020-10-14 | $128m |
| Xyphos Biosciences | Healthcare & Life Sciences | — | 2019-12-26 | $665m |
| Potenza Therapeutics | Healthcare & Life Sciences | — | 2018-12-14 | $165m |
| Quethera Ltd. | Healthcare & Life Sciences | — | 2018-08-10 | $131m |
| Mitobridge | Healthcare & Life Sciences | — | 2017-12-01 | $166m |
| Ogeda SA | Healthcare & Life Sciences | — | 2017-04-03 | $563m |
| Ganymed Pharmaceuticals AG | Healthcare & Life Sciences | — | 2016-10-28 | $476m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.